Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 06, 2024
CordenPharma has announced the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech customers. The investment, which is still being finalized, will be fully operational in Q2 2024 ...
read more
Wednesday, March 06, 2024
In 2023, the FDA Center for Drug Evaluation and Research (CDER) approved 55 new drugs, 17 of which were biopharmaceuticals. Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, ...
read more
Wednesday, March 06, 2024
Cresset, a provider of integrated in silico solutions for drug discovery has expanded its existing North American presence, with the creation of a new US facility in Boston, one of the world’s leading global hubs for pharma and life sciences.
read more
Wednesday, March 06, 2024
Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) certification for recombinant protein production and renewed the January 2023 GMP certification for DNA production at the facility located in ...
read more
Adare Pharma Solutions, a CDMO focused on oral dosage forms, announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.
read more
NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, announced its long-term strategic partnership with the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen.
read more
Argonaut Manufacturing Services announced the completion of a $45 million financing to support its new drug product fill/finish expansion. This expansion in Carlsbad, CA, underway since early 2023, includes a new dedicated facility with a state-of-...
read more
The Prange Group and its affiliate Adragos Pharma has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway - a leading sterile pharmaceutical manufacturing unit.
read more
Thursday, February 29, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform for several programs under the ...
read more
Wednesday, February 28, 2024
RRD International announced that it launched its new brand RRD Biopharma Development reflecting its unique offering of delivering strategy-driven product development services to biopharmaceutical companies and investors.
read more
Wednesday, February 28, 2024
Simtra BioPharma Solutions, a premier injectable contract development and manufacturing organization (CDMO), announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.
read more
Tuesday, February 27, 2024
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced positive top-line results from the company's Phase 2 clinical trial of VK2735, a dual ...
read more
Tuesday, February 27, 2024
Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced its new facility in Dublin, Ireland, to support global clinical trials.
read more
Tuesday, February 27, 2024
The artificial intelligence (AI) in drug discovery market is projected to reach USD 4.9 billion by 2028 from USD 900 million in 2023, at a CAGR of 40.2%
read more
Thursday, February 22, 2024
Immunocore Holdings announced that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb to investigate Immunocore’s ImmTAC bispecific TCR (T cell receptor) candidate targeting PRAME HLA-A02, IMC-F106C, in ...
read more